Position in XGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$473,463
-$1,765,497 QoQ
Shares Held
157,821
-57.1% QoQ
Ownership
0.653%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in XGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $1,107,116,506 across 33 Diagnostics & Research names. XGN ranks #28 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
4,229,531 | $390,681,778 | |
| 2 | DHR |
Danaher Corp /De/
|
1,858,782 | $352,425,067 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
187,893 | $92,355,046 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
176,557 | $84,780,905 | |
| 5 | A |
Agilent Technologies, Inc.
|
677,347 | $77,204,011 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
219,984 | $37,516,071 | |
| 7 | ILMN |
Illumina, Inc.
|
73,717 | $9,086,357 | |
| 8 | NTRA |
Natera, Inc.
|
40,200 | $8,039,598 |
All Filings in XGN
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $473,463 | 157,821 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,238,960 | 368,250 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,615,389 | 237,979 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $439,740 | 63,000 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||